Interventional Radiology Market Size, Share & Trends Analysis Report By Product (X-Ray, Ultrasound, Magnetic Resonance Imaging (MRI), Computed Tomography), By Application (Biopsy, Angioplasty, Angiography, Embolization, Radiofrequency Ablation, Vertebroplasty-kyphoplasty), By End User (Ambulatory Surgical Centers, Hospitals, Catheterization Labs) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034
Interventional Radiology Market Size
The interventional radiology market size was valued at USD 21 billion in 2025 and is projected to grow from USD 39 billion in 2026 to USD 46 billion by 2034 at a CAGR of 4.5% during the forecast period (2026-2034), as per Straits Research Analysis.
Interventional radiology continues to gain traction as healthcare systems prioritize treatments that reduce patient trauma and improve procedural outcomes. In 2025, more than 12 million IR procedures were reported worldwide, underscoring growing clinical adoption across therapeutic areas. Hospitals are increasingly integrating advanced imaging and navigation tools to enhance treatment precision and expand service offerings. Minimally invasive methods now account for a significant share of vascular and oncology interventions, reflecting clinician preference for efficient, less disruptive options. Patient demand also rises as awareness of IR benefits increases across age groups and disease profiles. Outpatient care units and specialty centers are becoming key delivery points, broadening access beyond traditional hospital settings. With demographic shifts and chronic disease prevalence climbing, the role of interventional radiology is positioned for continued expansion across global health networks.
Key Market Insights
- North America dominated the market with the largest share of 45% in 2025.
- The Asia Pacific is expected to be the fastest-growing region in the market during the forecast period at a CAGR of 6%.
- By product, the X-Ray segment accounted for the largest share of 55% in 2025.
- By end user, the ambulatory surgical centers segment is projected to grow at a CAGR of 6% during the forecast period.
- By application, the angiography segment accounted for the largest share of 30% in 2025.
- The US interventional radiology market size was valued at USD 9.43 billion in 2025 and is projected to reach USD 10 billion in 2026.
Market Summary
| Market Metric | Details & Data (2025-2034) |
|---|---|
| 2025 Market Valuation | USD 21 billion |
| Estimated 2026 Value | USD 39 billion |
| Projected 2034 Value | USD 46 billion |
| CAGR (2026-2034) | 4.5% |
| Dominant Region | North America |
| Fastest Growing Region | Asia Pacific |
| Key Market Players | Medtronic plc, Philips Healthcare, Siemens Healthcare, Agfa-Gevert N.V, Toshiba Medical Systems |
Download Free Sample Report to Get Detailed Insights.
Emerging Trends in Interventional Radiology Market
The rising demand for minimally invasive treatments encourages hospitals and healthcare providers to adopt interventional radiology techniques more widely. Many hospitals are shifting from traditional open surgeries to procedures like angioplasty, embolization, and image-guided biopsies, which reduce the physical trauma for patients. These procedures allow patients to recover more quickly and spend less time in the hospital, making treatments more convenient and comfortable. As a result, the overall volume of interventional radiology procedures increases steadily across areas such as cardiac care, oncology, and vascular interventions.
Innovations in imaging systems, robotics, AI-assisted navigation, and 3D visualization are significantly improving the accuracy and safety of interventional radiology procedures. Hospitals and clinics are integrating these technologies into their workflows to make treatments more precise and predictable. The improvements lead to higher procedural success rates and lower complication risks, which increases physician and patient confidence in these methods. This encourages more hospitals to invest in advanced IR equipment and expand their service offerings to attract a larger patient base.
Market Drivers
Expanding Insurance Coverage and Reimbursement Schemes Drives Market
Interventional radiology procedures are less resource-intensive and generally less expensive than open surgeries. Hospitals adopt these methods to manage costs while maintaining high-quality care, which increases patient demand. Suppliers benefit by providing cost-effective IR equipment and consumables that match hospital budgets. As more hospitals integrate IR into standard care, the number of procedures and overall market volume rise. The combined effect of reduced costs, higher adoption, and responsive supply contributes to market expansion.
Expanding insurance coverage and reimbursement schemes for interventional radiology procedures make them more affordable for patients. As a result, more patients choose IR over traditional surgical methods, increasing service demand at hospitals and clinics. Hospitals invest in additional IR equipment and trained staff to handle the rising patient volume. Medical device manufacturers scale production to meet this increased hospital demand. This synergy between policy support, patient affordability, and supply availability accelerates market expansion.
Market Restraints
Continued Preference for Conventional Treatment Approaches and Strict Government Regulations Restrain Interventional Radiology Market Growth
Strict government regulations and medical device approval processes create barriers for hospitals and suppliers. Hospitals must comply with multiple safety, licensing, and procedural standards before offering IR services. These requirements increase setup time and operational costs for hospitals. As a result, adoption rates slow down in regions with complex regulatory frameworks, limiting market expansion.
Traditional open surgeries remain widely practiced due to familiarity, established protocols, and lower initial investment. Physicians and hospitals prefer these conventional methods over IR procedures for certain cases, which reduces adoption despite its minimally invasive benefits. As a result, market growth is restrained by the continued preference for conventional treatment approaches.
Market Opportunities
Expansion of Outpatient and Ambulatory Care Centers and Medical Tourism Offer Growth Opportunities for Interventional Radiology Market Players
Outpatient and ambulatory care centers are expanding rapidly as patients increasingly prefer treatments that involve shorter hospital stays, faster recovery, and lower disruption to daily life. These centers are well-positioned to adopt interventional radiology procedures because IR offers minimally invasive solutions that can be performed efficiently in a lower-resource setting. This creates opportunities for smaller hospitals and clinics to provide high-quality IR services without the need for large infrastructure investments or extensive inpatient facilities. Thus, medical device manufacturers focus on offering compact, portable, and cost-effective equipment, as well as consumables designed specifically for outpatient use, to support this growing segment.
Regions with advanced services attract international patients seeking high-quality care at competitive costs. Hospitals can leverage medical tourism to increase procedure volumes and revenue, which presents opportunities for hospitals to expand IR departments, upgrade technologies, and offer comprehensive care packages. Suppliers benefit by providing advanced equipment to meet the higher demand from internationally referred patients.
Regional Insights
North America: Market Dominance through High Burden of Chronic Diseases and High Healthcare Spending
North America dominated the market with the largest share of 45% in 2025. This growth is attributed to the high burden of chronic diseases such as cardiovascular disorders, cancer, diabetes-related complications, and peripheral artery disease. The widespread prevalence of these conditions drives strong demand for minimally invasive, image-guided procedures like angiography, angioplasty, embolization, radiofrequency ablation, and vertebroplasty, resulting in higher procedural volumes and encouraging adoption of advanced technologies in hospitals, cath labs, and ambulatory surgical centers.
The US dominated the North America interventional radiology market due to its high healthcare spending, which enables widespread adoption of advanced imaging technologies, minimally invasive procedures, and cutting-edge interventional devices. Substantial per capita expenditure supports high procedural volumes, rapid integration of AI-assisted and robotic interventions, and the ability of hospitals and ambulatory surgical centers to invest in state-of-the-art equipment, ensuring greater access to interventional radiology services across the country.
In Canada, the market is growing due to the increasing adoption of image-guided procedures, driven by a focus on minimally invasive treatments, improved patient outcomes, and reduced hospital stays. Canadian hospitals and specialized clinics are expanding the use of angiography, embolization, radiofrequency ablation, and vertebroplasty, supported by advanced imaging systems and government initiatives promoting efficient, high-quality healthcare. This shift toward image-guided interventions is enhancing procedural accuracy and boosting overall demand for interventional radiology services in the country.
Asia Pacific: Fastest Growth through Healthcare Investments and Increasing Integration of Image-guided Procedures
The Asia Pacific region is expected to be the fastest-growing region in the market during the forecast period at a CAGR of 6%. The market is expanding rapidly due to technological adoption and market development. Hospitals, diagnostic centers, and specialized clinics are increasingly implementing advanced imaging technologies, including CT, MRI, fluoroscopy, and digital angiography systems, as well as AI-assisted and robotic-guided procedures. This enables more accurate, minimally invasive interventions, improves procedural efficiency, and enhances patient outcomes. Coupled with expanding hospital infrastructure and growing private healthcare investments, this technological adoption is driving both market penetration and procedural volume growth across key APAC.
In China, the market is being strongly supported by government healthcare investments aimed at expanding access to modern medical facilities and advanced diagnostic technologies. Initiatives under the Healthy China 2030 plan focus on upgrading hospitals, building new imaging and outpatient centers, and increasing the availability of minimally invasive procedures. These investments include funding for CT, MRI, fluoroscopy, and digital angiography equipment, as well as training programs for skilled interventional radiologists. As a result, the government’s strategic support is accelerating the adoption of interventional radiology in China.
In India, the interventional radiology market is witnessing rapid growth due to increasing patient awareness about minimally invasive, image-guided procedures. With rising knowledge of the benefits such as shorter recovery times, reduced complications, and shorter hospital stays, patients are increasingly opting for procedures like angiography, angioplasty, embolization, and radiofrequency ablation. Awareness campaigns by hospitals, healthcare providers, and digital health platforms, along with improved access to diagnostic imaging centers in urban and semi-urban areas, are driving higher demand for interventional radiology services across the country.
By Product
The X-Ray segment accounted for the largest share of 55% in 2025. Its growth is driven by the high procedural volume in hospitals and catheterization labs, cost-effectiveness, and critical role in guiding vascular interventions. X-ray systems, including digital flat-panel detectors and mobile C-arms, are extensively adopted for angioplasty, stenting, and embolization procedures, making it the preferred imaging modality for most interventional radiology applications.
The ultrasound segment is projected to grow at a CAGR of 6% during the forecast period due to increasing adoption of non-invasive, real-time imaging for biopsy, vascular, and abdominal interventions. Growth in this segment is driven by rising demand for minimally invasive procedures, lower cost compared to MRI and CT, portability of ultrasound devices, and increasing awareness among clinicians and patients of safer, radiation-free imaging techniques.
By End User
The hospitals segment accounted for the largest share of 55% in 2025. Growth in this segment is driven by the availability of advanced imaging infrastructure, high patient throughput, and a wide range of complex procedures such as angiography, angioplasty, embolization, and radiofrequency ablation. Hospitals, including tertiary care and multi-specialty centers, serve as the primary hubs for interventional radiology, supported by highly trained radiologists and well-established reimbursement systems.
The ambulatory surgical centers segment is projected to grow at a CAGR of 6% during the forecast period. Unlike hospitals, ASCs focus on outpatient procedures, allowing patients to undergo minimally invasive, image-guided interventions such as angiography, angioplasty, embolization, biopsies, and radiofrequency ablation without overnight hospitalization. Growth is driven by the shift toward outpatient care, cost-effective procedures, rising adoption of minimally invasive, image-guided interventions, increasing patient awareness, and supportive reimbursement frameworks.
By Application
The angiography segment accounted for the largest share of 30% in 2025. Hospitals and catheterization labs extensively use angiography for real-time imaging, making it the backbone of interventional procedures. Its growth is driven by the critical role of angiography in diagnosing and guiding vascular interventions, including angioplasty, stenting, and embolization procedures.
The biopsy segment is projected to grow at a CAGR of 6% during the forecast period, owing to the rising demand for minimally invasive tissue sampling for cancer and chronic disease diagnosis. Growth in this segment is supported by advancements in imaging guidance (ultrasound, CT, and MRI), increasing patient awareness of early disease detection, and expanding adoption in hospitals and ambulatory surgical centers.
Competitive Landscape
The competitive landscape of the interventional radiology market is broadly fragmented, with a mix of large multinational medical technology companies, specialized imaging and device manufacturers, regional equipment producers, and emerging niche innovators all vying for share. Established players typically compete on breadth of product portfolio, global distribution networks, regulatory approvals, and longstanding relationships with major hospital systems, offering integrated imaging platforms and comprehensive therapy solutions. Emerging firms and new entrants tend to focus on innovation, costeffective systems, AIenabled software, and specialized tools for outpatient or lowerresource settings to differentiate themselves and capture specific segments of demand.
List of Key and Emerging Players in Interventional Radiology Market
- Medtronic plc
- Philips Healthcare
- Siemens Healthcare
- Agfa-Gevert N.V
- Toshiba Medical Systems
- Hitachi Medical Corporation
- Teleflex Incorporated
- Fujifilm Holdings
- Canon Medical Systems Corporation
- Stereotaxis
- GE HealthCare
- Radicait
- Microbot Medical
- Interventional Systems
Recent Developments
- In March 2026, GE HealthCare showcased the Allia Moveo system at ECR 2026, a nextgeneration imaging platform designed for enhanced interventional workflows and supporting more efficient minimally invasive procedures.
- In January 2026, Stereotaxis secured FDA approval for its MAGiC magnetic interventional ablation catheter, adding a proprietary robotic catheter to its portfolio.
- In November 2025, Stereotaxis received US FDA 510(k) clearance for its GenesisX robotic magnetic navigation system, a compact robot designed to fit existing cath labs and expand access to robotic procedures.
- In October 2025, Radicait secured funding to develop AI-based synthetic diagnostic imaging solutions.
- In September 2025, Microbot Medical received FDA 510(k) clearance for its Liberty endovascular robotic system, which is a singleuse, remotely operated robotic platform for peripheral vascular procedures.
- In September 2025, Interventional Systems and Siemens Healthineers entered into an agreement to promote roboticsassisted procedures in angiography suites by combining robotics accuracy with advanced imaging infrastructure.
Report Scope
| Report Metric | Details |
|---|---|
| Market Size in 2025 | USD 21 billion |
| Market Size in 2026 | USD 39 billion |
| Market Size in 2034 | USD 46 billion |
| CAGR | 4.5% (2026-2034) |
| Base Year for Estimation | 2025 |
| Historical Data | 2022-2024 |
| Forecast Period | 2026-2034 |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
| Segments Covered | By Product, By Application, By End User |
| Geographies Covered | North America, Europe, APAC, Middle East and Africa, LATAM |
| Countries Covered | US, Canada, UK, Germany, France, Spain, Italy, Russia, Nordic, Benelux, China, Korea, Japan, India, Australia, Singapore, Taiwan, South East Asia, UAE, Turkey, Saudi Arabia, South Africa, Egypt, Nigeria, Brazil, Mexico, Argentina, Chile, Colombia |
Download Free Sample Report to Get Detailed Insights.
Interventional Radiology Market Segments
By Product
- X-Ray
- Ultrasound
- Magnetic Resonance Imaging (MRI)
- Computed Tomography
By Application
- Biopsy
- Angioplasty
- Angiography
- Embolization
- Radiofrequency Ablation
- Vertebroplasty-kyphoplasty
By End User
- Ambulatory Surgical Centers
- Hospitals
- Catheterization Labs
By Region
- North America
- Europe
- APAC
- Middle East and Africa
- LATAM
Frequently Asked Questions (FAQs)
Debashree Bora
Healthcare Lead
Debashree Bora is a Healthcare Lead with over 7 years of industry experience, specializing in Healthcare IT. She provides comprehensive market insights on digital health, electronic medical records, telehealth, and healthcare analytics. Debashree’s research supports organizations in adopting technology-driven healthcare solutions, improving patient care, and achieving operational efficiency in a rapidly transforming healthcare ecosystem.
